Cargando…
Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million people worldwide making it an under recognised, but significant health problem across the globe, conferring significant morbidity and mortality. With variable disease forms, high levels of associated respiratory co-morbidity, lim...
Autores principales: | Hayes, Gemma E., Novak-Frazer, Lilyann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753080/ https://www.ncbi.nlm.nih.gov/pubmed/29376935 http://dx.doi.org/10.3390/jof2020018 |
Ejemplares similares
-
Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018) -
Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017) -
Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021) -
Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021) -
Colon Capsule Endoscopy: Where Are We and Where Are We Going
por: Han, Yoo Min, et al.
Publicado: (2016)